These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25495365)

  • 1. Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease.
    Miller VM
    J Womens Health (Larchmt); 2014 Dec; 23(12):997-1004. PubMed ID: 25495365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Joint position statement of Polish Gynecologic Society, Polish Cardiological Society, and Polish Menopause and Andropause Society on the effect of hormone replacement therapy on cardiovascular system].
    Kornacewicz-Jach Z; Czarnecka D; Rynkiewicz A; Kotarski J; Paszkowski T; Pertyński T; Debski R; Wielgoś M
    Kardiol Pol; 2009 Jan; 67(1):72-6. PubMed ID: 19253195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estrogen and cardiovascular diseases].
    Mikkola T; Tikkanen MJ
    Duodecim; 2003; 119(22):2191-7. PubMed ID: 14702808
    [No Abstract]   [Full Text] [Related]  

  • 4. [Should hormone replacement therapy for menopause be continued in diabetic women?].
    Skurnik G; Touraine P
    Journ Annu Diabetol Hotel Dieu; 2004; ():151-60. PubMed ID: 15259313
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease prevention in women and the hormone debate.
    MacPherson KI
    AWHONNS Clin Issues Perinat Womens Health Nurs; 1993; 4(2):244-9. PubMed ID: 8242046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.
    Harman SM
    Fertil Steril; 2014 Apr; 101(4):887-97. PubMed ID: 24680648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of menopause management and menopausal related hormone replacement therapy].
    Yu Q
    Zhonghua Fu Chan Ke Za Zhi; 2013 Apr; 48(4):287-90. PubMed ID: 23902813
    [No Abstract]   [Full Text] [Related]  

  • 9. Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection.
    Oparil S
    Hypertension; 1999 Jan; 33(1 Pt 2):170-6. PubMed ID: 9931100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies.
    Turgeon JL; Carr MC; Maki PM; Mendelsohn ME; Wise PM
    Endocr Rev; 2006 Oct; 27(6):575-605. PubMed ID: 16763155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In memoriam: Trudy L. Bush.
    Herrington DM; Barrett-Connor E
    J Womens Health Gend Based Med; 2001 Apr; 10(3):215-6. PubMed ID: 11389777
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular and metabolic effects of sex steroids: new insights into clinical trials.
    Wierman ME; Kohrt WM
    Reprod Sci; 2007 May; 14(4):300-14. PubMed ID: 17644802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sex hormones and physiological function].
    Yamatani H; Takahashi K; Nagase S
    Nihon Rinsho; 2015 Apr; 73(4):565-70. PubMed ID: 25936142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone replacement and cardiovascular disease: incorporating research into practice.
    Chase SK; Youngkin EQ
    J Obstet Gynecol Neonatal Nurs; 2004; 33(5):648-56. PubMed ID: 15495711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.
    Ouyang P; Michos ED; Karas RH
    J Am Coll Cardiol; 2006 May; 47(9):1741-53. PubMed ID: 16682298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Women's Health Initiative tells us more about what estrogen can and cannot do but does not give us the answer.
    Richardson MK
    Menopause; 2010 Mar; 17(2):235-6. PubMed ID: 20216273
    [No Abstract]   [Full Text] [Related]  

  • 17. Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis".
    Sowers MR; Randolph J; Jannausch M; Lasley B; Jackson E; McConnell D
    Arch Intern Med; 2008 Oct; 168(19):2146-53. PubMed ID: 18955645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential anabolic effects of androgens on bone.
    Kearns AE; Khosla S
    Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S14-8. PubMed ID: 15065633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.